As of 2026-10-08, the Relative Valuation of Twist Bioscience Corp (TWST) is (42.11) USD. This relative valuation is based on P/E multiples. With the latest stock price at 155.65 USD, the upside of Twist Bioscience Corp based on Relative Valuation is -127.1%.
The range of the Relative Valuation is (38.23) - (44.42) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.4x - 27.5x | 23.0x |
| Forward P/E multiples | 21.4x - 24.8x | 24.2x |
| Fair Price | (38.23) - (44.42) | (42.11) |
| Upside | -124.6% - -128.5% | -127.1% |
| Date | P/E |
| 2026-10-07 | -87.04 |
| 2026-10-06 | -93.37 |
| 2026-10-05 | -114.64 |
| 2026-10-02 | -105.51 |
| 2026-10-01 | -105.16 |
| 2026-09-30 | -108.06 |
| 2026-09-29 | -104.08 |
| 2026-09-28 | -100.43 |
| 2026-09-25 | -102.24 |
| 2026-09-24 | -102.91 |
| 2026-09-23 | -88.63 |
| 2026-09-22 | -92.04 |
| 2026-09-21 | -92.73 |
| 2026-09-18 | -93.38 |
| 2026-09-17 | -86.99 |
| 2026-09-16 | -80.01 |
| 2026-09-15 | -77.23 |
| 2026-09-14 | -75.35 |
| 2026-09-11 | -71.14 |
| 2026-09-10 | -70.94 |
| 2026-09-09 | -70.19 |
| 2026-09-08 | -71.61 |
| 2026-09-04 | -69.74 |
| 2026-09-03 | -71.98 |
| 2026-09-02 | -73.26 |
| 2026-09-01 | -73.85 |
| 2026-08-31 | -77.73 |
| 2026-08-28 | -79.06 |
| 2026-08-27 | -85.61 |
| 2026-08-26 | -83.91 |
| 2026-08-25 | -84.67 |
| 2026-08-24 | -78.74 |
| 2026-08-21 | -81.41 |
| 2026-08-20 | -76.24 |
| 2026-08-19 | -79.63 |
| 2026-08-18 | -64.92 |
| 2026-08-17 | -69.57 |
| 2026-08-14 | -66.30 |
| 2026-08-13 | -70.06 |
| 2026-08-12 | -70.02 |
| 2026-08-11 | -68.85 |
| 2026-08-10 | -69.83 |
| 2026-08-07 | -64.68 |
| 2026-08-06 | -61.00 |
| 2026-08-05 | -64.31 |
| 2026-08-04 | -55.61 |
| 2026-08-03 | -56.51 |
| 2026-07-31 | -51.20 |
| 2026-07-30 | -51.07 |
| 2026-07-29 | -47.80 |